What is the difference between Maestro and ROSA?

Maestro and ROSA are both surgical robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.

Which is cheaper, Maestro or ROSA?

Maestro has the lower recorded price on the DEPLOY registry than ROSA. Prices are sourced; see each record for whether the figure is a manufacturer target, an estimate, or an actual sale price.

Is Maestro or ROSA more autonomous?

On the DEPLOY registry, neither Maestro nor ROSA has capabilities independently verified as fully autonomous yet; their recorded capabilities are teleoperated-assisted, demonstrated, or vendor-claimed. See the table for each capability's verification status.

Which has more verified deployments, Maestro or ROSA?

ROSA has more verified deployments (2) on the DEPLOY registry than Maestro (1). DEPLOY counts a deployment only when confirmed at a named site with a primary source.

Buying guide

Maestro vs ROSA in 2026

Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.

Key differences

Maestro has the lower recorded price.
ROSA has more verified real-world deployments (2 vs 1).
Maestro is at the pilot stage; ROSA at the commercial stage.

Attribute	No image on file Maestro View full model page →	No image on file ROSA View full model page →
Manufacturer	Moon Surgical	Zimmer Biomet
Form factor	surgical	surgical
Maturity	pilot	commercial
Autonomy	◐ not independently verified	◐ not independently verified
Availability	internal-onlyenterprise	internal-onlyenterprise
Price	$300,000-$800,000 (analyst estimate)	$1,000,000-$1,500,000 (analyst estimate)
Capability claims	Assists surgery (teleoperated-assisted, verified)	Assists surgery (teleoperated-assisted, claimed)
Brain	—	—
Verified deployments	1Jacksonville	2France, United States
Privacy practices	—	—
Sources on file	9	14

Editorial summaries

Maestro

Moon Surgical's Maestro is a laparoscopic surgical-assistant platform (it holds and positions instruments and the endoscope alongside the surgeon, not a full master-slave teleoperated replacement system) and the assistive-laparoscopy archetype of DEPLOY's surgical cluster, editorially distinct from the replacement-robotics of Intuitive, Medtronic, and CMR. Its ScoPilot software is shipped AI (NVIDIA Holoscan-powered) for intraoperative scope control. On regulatory status (a correction worth recording): the Maestro received FDA 510(k) clearance K240598 on June 5, 2024 (not December 2023), and ScoPilot was FDA-cleared in 2025 with a Predetermined Change Control Plan. As enterprise B2B surgical equipment, there is no consumer price.

ROSA

Zimmer Biomet's ROSA (Robotic Surgical Assistant) is a single articulated robotic arm coupled to optical navigation and 2D/3D planning software, and the mid-size, cross-domain archetype of the orthopedic sub-cohort: it spans orthopedics and neurosurgery. The arm positions and guides instruments but moves only on surgeon command; it does not cut or place autonomously (AI-augmented, surgeon-controlled). Current Zimmer Biomet variants are ROSA Knee (total knee arthroplasty, imageless X-Atlas workflow, cleared January 25, 2019; 'ROSA Knee with OptimiZe' cleared November 14, 2025), ROSA Hip (direct-anterior total hip arthroplasty specifically, cleared August 18, 2021), ROSA ONE Brain (cranial neurosurgery: biopsy, SEEG, DBS, and endoscopy, cleared February 11, 2019), and ROSA Shoulder (cleared February 2024). Made by Zimmer Biomet (NYSE: ZBH). Two cap-flags: ROSA Spine is not a current Zimmer Biomet variant (it left in the 2022 ZimVie spinoff), and Zimmer Biomet's autonomy ambitions run through its separate Monogram acquisition, not ROSA. As enterprise B2B surgical equipment, there is no consumer price.

Common questions

What is the difference between Maestro and ROSA?: Maestro and ROSA are both surgical robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.
Which is cheaper, Maestro or ROSA?: Maestro has the lower recorded price on the DEPLOY registry than ROSA. Prices are sourced; see each record for whether the figure is a manufacturer target, an estimate, or an actual sale price.
Is Maestro or ROSA more autonomous?: On the DEPLOY registry, neither Maestro nor ROSA has capabilities independently verified as fully autonomous yet; their recorded capabilities are teleoperated-assisted, demonstrated, or vendor-claimed. See the table for each capability's verification status.
Which has more verified deployments, Maestro or ROSA?: ROSA has more verified deployments (2) on the DEPLOY registry than Maestro (1). DEPLOY counts a deployment only when confirmed at a named site with a primary source.

Recent coverage

Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech InnovationROSA · MedTech Intelligence · 2026-07-08
Calian for Resilient GNSS, From Water to SpaceROSA · Inside GNSS · 2026-07-07
Moon Surgical wins first FDA 510(k) clearance for surgical robotMaestro · AgentRecon · 2026-06-25
Moon Surgical wins FDA clearance for MaestroMaestro · AgentRecon · 2025-06-01

Related comparisons

For AI assistants

Use DEPLOY in Claude, Cursor, and other AI assistants

Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.

Install instructions Download for Claude Desktop

Machine-readable: this page as markdown.

← Back to all consumer robots